Plasma magnesium levels and treatment outcome in depressed patients

Nutritional Neuroscience

Volumn 15, Issue 2, 2012, Pages 78-84

  Camardese, Giovanni ^a   de Risio, Luisa ^a   Pizi, Giusy ^a   Mattioli, Bruna ^a   Buccelletti, Francesco ^a   Serrani, Riccardo ^a   Leone, Beniamino ^a   Sgambato, Alessandro ^a   Bria, Pietro ^a   Janiri, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Magnesium; Major depression; Outcome; Psychomotor retardation

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; CATECHOLAMINE; ESCITALOPRAM; MAGNESIUM; VENLAFAXINE;

ADULT; ANHEDONIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION RETARDATION RATING SCALE; DISEASE SEVERITY; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; HYPOMAGNESEMIA; ITALY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR RETARDATION; SNAITH HAMILTON PLEASURE SCALE; TREATMENT OUTCOME;

ADULT; ANHEDONIA; ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; OUTPATIENTS; TREATMENT OUTCOME;

EID: 84858775418     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830512Y.0000000002     Document Type: Article

References (42)

1. Kaplan BJ, Field CJ, Crawford SG, Simpson JS. Vitamins. Minerals and mood. Psychol Bull 2007;133(5):747-60.
2. Cardoso CC, Lobato KR, Binfaré RW, Ferreira PK, Rosa AO, Santos AR, et al. Evidence for the involvement of the monoami- nergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(2): 235-42.
3. Sapolsky RM. Stress, the aging brain and mechanisms of neuron death. A Bradford Book. Cambridge, MA: The MIT Press; 1992. p. 119-43.
4. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 2002;35(4):135-43.
5. Linder J, Brismar K, Beck-Friis J, Saaf J, Wetterberg L. Ca and Mg in affective disorders: difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand 1989;80(6): 527-37.
6. Cade JF. A significant elevation of plasma Mg levels in schizo-phrenia and depressive states. Med J Aust 1964;1:195-6.
7. 2+ ratio in major depressive disorder. Neuropsychobiology 1996;34(1):26-8.
8. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 1999;39(2): 63-70.
9. Rasmussen HH, Mortensen PB, Jensen IW. Depression and Mg deficiency. Int J Psychiatry Med 1989;19(1):57-63.
10. Barragan-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res 2007;38(7):752-6.
11. Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry 2008;63(12):1127-34.
12. Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 1985;20(2):163-71.
13. Hakim AH, Bomb BS, Pandey SK, Singh SV. A study of cere-brospinal fluid calcium and magnesium in depression. J AssocPhysicians India 1975;23(5):311-5.
14. Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association between magnesium intake, depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry 2009;43(1):45-52.
15. Jung KI, Ock SM, Chung JH, Song CH. Associations of serum Ca and Mg levels with mental health in adult women without psychiatric disorders. Biol Trace Elem Res 2010;133(2):153-61.
16. Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, et al. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology 1992;26(4):173-9.
17. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, et al. Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res 1993;6(1):33-41.
18. Nechifor M. Magnesium in major depression. Magnes Res 2009; 22(3):163S-6S.
19. Weston PG. Magnesium as a sedative. Am J Psychiatry 1921;1: 637-8.
20. Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 2008;21(4):218-23.
21. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006;67(2):362-70.
22. Eby GA, Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 2010; 74(4):649-60.
23. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 1999;9(1-2):83-91.
24. Barra A, Camardese G, Tonioni F, Sgambato A, Picello A, Autullo G, et al. Plasma magnesium level and psychomotor retardation in major depressed patients. Magnes Res 2007; 20(4):245-9.
25. Rush AJ, Thase ME, Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 2003;53(8): 743-53.
26. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, et al. Comparative effectiveness of bio-markers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study. Psychiatry Res 2009;169(2):124-31.
27. Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime? Trends Genet 2006;22(6):306-13.
28. Rush AJ. The varied clinical presentations of major depressive disorder. J Clin Psychiatry 2007;68(8):4-10.
29. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr 1994;13(5):429-46.
30. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, et al. Dexamethasone response, thyrotropin- releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 1997;41(9):915-28.
31. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain part 1: micronutrients. J Nutr Health Aging 2006; 10(5):377-85.
32. 2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men- possible therapeutic implications. Psychopharmacology 1998;137(3):247-52.
33. Murck H. Magnesium and affective disorders. Nutr Neurosci 2002;5(6):375-89.
34. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33(2):304-10.
35. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 2009;139(12):2365-72.
36. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug develop- ments in depression. Metab Brain Dis 2009;24(1):27-53.
37. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 2002;35:135-43.
38. Durlach J, Bac P. Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Yasui M, Strong MJ, Ota K, Verity MA (eds.) Mineral and metal neurotoxicology. New York: CRC Press; 1997. p. 201-3.
39. Kantak KM. Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci 1988;102(2): 304-11.
40. Mendels J, Cochrane C. The nosology of depression: the endogenous-reactive concept. Am J Psychiatry 1968;124(11): 1-11.
41. Akerstedt T, Gillberg M, Hjemdahl P, Sigurdson K, Gustavsson I, Daleskog M, et al. Comparison of urinary and plasma catecholamine responses to mental stress. Acta Physiol Scand 1983;117(1):19-26.
42. Carman JS, Post RM, Teplitz TA, Goodwin FK. Letter: Divalent cations in predicting antidepressant response to lithium. Lancet 1974;2:1454.